Literature DB >> 22850284

Stem cell factor is responsible for the rapid response in mature mast cell density in the acutely stressed heart.

Jianping Li1, Hong Lu, Eric Plante, Giselle C Meléndez, Scott P Levick, Joseph S Janicki.   

Abstract

In the abdominal aortocaval (AV) fistula model of heart failure, we have shown that the acute doubling of cardiac mature mast cell (MC) density involved the maturation, but not proliferation, of a resident population of immature cardiac MCs. An increase in stem cell factor (SCF) may be responsible for this MC maturation process. Thus, the purpose of this study was to determine if: 1) myocardial SCF levels are increased following the initiation of cardiac volume overload; 2) the incubation of left ventricular (LV) tissue slices with SCF results in an increase in mature MC density; and 3) chemical degranulation of mature cardiac MCs in LV tissue slices results in an increase in SCF and mature MC density via MC chymase. Male rats with either sham or AV fistula surgery were studied at 6h and 1 and 3 days post-surgery. LV slices from normal male rat hearts were incubated for 16h with media alone or media containing one of the following: 1) recombinant rat SCF (20 ng/ml) to determine the effects of SCF on MC maturation; 2) the MC secretagogue compound 48/80 (20 μg/ml) to determine the effects of MC degranulation on SCF levels and mature MC density; 3) media containing compound 48/80 and anti-SCF (5 μg/ml) to block the effects of SCF; 4) chymase (100 nM) to determine the effects of chymase on SCF; and 5) compound 48/80 and chymostatin (chymase inhibitor, 10 μM) to block the effects of MC chymase. In AV fistula animals, myocardial SCF was significantly elevated above that in the sham group at 6h and 1 day post fistula by 2 and 1.8 fold, respectively, and then returned to normal by 3 days; this increase slightly preceded significant increases in MC density. Incubation of LV slices with SCF resulted in a doubling of mature MC density and this was concomitant with a significant decrease in the number of immature mast cells. Incubation of LV slices with compound 48/80 increased media SCF levels and mature MC density and with anti-SCF and chymostatin prevented these compound 48/80-induced increases. Incubation with chymase increased media SCF levels and mature MC density. These findings indicate that activated mature cardiac mast cells are responsible, in a paracrine fashion, for the increase in mature MC density post AV fistula by rapidly increasing SCF levels via the release of chymase.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850284      PMCID: PMC3438908          DOI: 10.1016/j.yjmcc.2012.07.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  34 in total

1.  MAST CELLS AND CORONARY HEART DISEASE. RELATIONSHIP BETWEEN NUMBER OF MAST CELLS IN THE MYOCARDIUM, SEVERITY OF CORONARY ATHEROSCLEROSIS AND MYOCARDIAL INFARCTION IN AN AUTOPSY SERIES OF 672 CASES.

Authors:  M FERNEX; N H STERNBY
Journal:  Acta Pathol Microbiol Scand       Date:  1964

2.  Chymase cleavage of stem cell factor yields a bioactive, soluble product.

Authors:  B J Longley; L Tyrrell; Y Ma; D A Williams; R Halaban; K Langley; H S Lu; N M Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Identification of mast cell progenitors in adult mice.

Authors:  Ching-Cheng Chen; Michele A Grimbaldeston; Mindy Tsai; Irving L Weissman; Stephen J Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

4.  Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis.

Authors:  Yojiro Arinobu; Hiromi Iwasaki; Michael F Gurish; Shin-ichi Mizuno; Hirokazu Shigematsu; Hidetoshi Ozawa; Daniel G Tenen; K Frank Austen; Koichi Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

5.  Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.

Authors:  Montserrat Batlle; Eulàlia Roig; Fèlix Perez-Villa; Sergio Lario; Pilar Cejudo-Martin; Ester García-Pras; José Ortiz; Mercé Roqué; Josefina Orús; Montserrat Rigol; Magdalena Heras; José Ramírez; Wladimiro Jimenez
Journal:  J Heart Lung Transplant       Date:  2006-08-09       Impact factor: 10.247

6.  Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats.

Authors:  Gregory L Brower; Joseph S Janicki
Journal:  J Card Fail       Date:  2005-09       Impact factor: 5.712

Review 7.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  Rat cardiac mast cell maturation and differentiation following acute ventricular volume overload.

Authors:  M F Forman; G L Brower; J S Janicki
Journal:  Inflamm Res       Date:  2006-10       Impact factor: 4.575

Review 9.  Stem cell factor expression, mast cells and inflammation in asthma.

Authors:  Carla A Da Silva; Laurent Reber; Nelly Frossard
Journal:  Fundam Clin Pharmacol       Date:  2006-02       Impact factor: 2.748

10.  Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy.

Authors:  V Patella; I Marinò; E Arbustini; B Lamparter-Schummert; L Verga; M Adt; G Marone
Journal:  Circulation       Date:  1998-03-17       Impact factor: 29.690

View more
  13 in total

1.  Substance P induces cardioprotection in ischemia-reperfusion via activation of AKT.

Authors:  Shaiban Jubair; Jianping Li; Heather M Dehlin; Edward J Manteufel; Paul H Goldspink; Scott P Levick; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

2.  THE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSIS.

Authors:  Jianping Li; Shaiban Jubair; Scott P Levick; Joseph S Janicki
Journal:  IJC Metab Endocr       Date:  2015-11-24

Review 3.  Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase.

Authors:  Joseph S Janicki; Francis G Spinale; Scott P Levick
Journal:  Pflugers Arch       Date:  2013-02-16       Impact factor: 3.657

4.  Chymase-dependent production of angiotensin II: an old enzyme in old hearts.

Authors:  Ghezal Froogh; John T Pinto; Yicong Le; Sharath Kandhi; Yeabsra Aleligne; An Huang; Dong Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-11-04       Impact factor: 4.733

5.  The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Scott P Levick
Journal:  Methods Mol Biol       Date:  2015

Review 6.  Myofilament dysfunction as an emerging mechanism of volume overload heart failure.

Authors:  Kristin Wilson; Pamela A Lucchesi
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

7.  GPR30 decreases cardiac chymase/angiotensin II by inhibiting local mast cell number.

Authors:  Zhuo Zhao; Hao Wang; Marina Lin; Leanne Groban
Journal:  Biochem Biophys Res Commun       Date:  2015-02-21       Impact factor: 3.575

Review 8.  Histamine receptors in heart failure.

Authors:  Scott P Levick
Journal:  Heart Fail Rev       Date:  2021-10-08       Impact factor: 4.654

Review 9.  Substance P in heart failure: the good and the bad.

Authors:  Heather M Dehlin; Scott P Levick
Journal:  Int J Cardiol       Date:  2013-11-12       Impact factor: 4.164

10.  Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle.

Authors:  Himal Luitel; Akylbek Sydykov; Yves Schymura; Argen Mamazhakypov; Wiebke Janssen; Kabita Pradhan; Astrid Wietelmann; Djuro Kosanovic; Bhola Kumar Dahal; Norbert Weissmann; Werner Seeger; Friedrich Grimminger; Hossein Ardeschir Ghofrani; Ralph Theo Schermuly
Journal:  Physiol Rep       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.